Blood samples could unlock secrets of rare brain diseases
NCT ID NCT04698421
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study collects blood samples from 1000 people with rare neurological diseases that may be autoimmune. Researchers will use the samples to find new biomarkers and autoantibodies, which could help diagnose and treat these conditions in the future. Participants give extra blood during routine visits, and no experimental treatment is given.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify new biomarkers and autoantibodies, pointing toward better diagnostics and treatments for rare neurological diseases.
- What could go wrong
- This is an observational sample collection study, not a treatment trial. It may not directly lead to new therapies, and results depend on future research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NERVOUS SYSTEM DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Purpan University Hospital
RECRUITINGToulouse, 31059, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?
- Could a lifestyle makeover keep your brain sharp?
- Testosterone may rebuild strength after spinal cord injury — trial puts it to the test
- Massive global registry aims to unlock secrets of rett syndrome
- Spinal stimulation may steady blood pressure after spinal cord injury